The NCI Cancer Center Support Grant to the Abramson Cancer Center (ACC) has funded the Biostatistics Core continuously since its establishment in 1978. This Core was rated ?Exceptional? in the last renewal. The Core provides expert biostatistical guidance in the design, conduct, and analysis of research projects conducted by cancer center members, and offers training in the fundamentals of design and analysis to the Penn cancer research community. Core personnel are prepared not only to apply existing methods of design and analysis, but also to modify or develop new methods to address novel design and analysis issues arising in cancer research projects. A major responsibility is to support the design of clinical trials; as such, the Biostatistics Core plays a key role in the Protocol Review and Monitoring System, particularly through the Clinical Trials Scientific Review and Monitoring Committee. Access to the Core is limited to ACC members. Andrea Troxel, ScD, Professor of Biostatistics, has served as a Core member since 2004 and as Director of the Biostatistics Core since 2014; she leads an accomplished and highly collaborative team drawn from the faculty of the Penn Department of Biostatistics and Epidemiology. During the current project period, the Biostatistics Core has continued to be a dynamic presence in the ACC, providing collaborative biostatistical support services across the spectrum of cancer research. Participation of the Core has been essential to the funding of numerous currently funded grants, including three P01s, three P50s (including two SPOREs), one P60, one P42, two U01s, and one U54 in areas such as skin cancer, ovarian cancer, prostate and testicular cancer, thoracic cancers, esophageal cancer, smoking cessation research, and environmental carcinogenesis, as well as 25 R01s, six R21s, several K-series grants, and numerous foundation and state government grants. During the current project period, the Core has added strength in statistical methods for genetic data, clinical prediction, and pediatric oncology. Core members have co-authored roughly 400 publications in the current project period. In the upcoming grant cycle, the Core will assume responsibility for data management in the ACC, subsuming the role of the Biomedical Data Coordination Core. In summary, the Biostatistics Core is composed of a superbly qualified, productive, versatile and highly collaborative team of biostatistics and data management professionals who are deeply involved in supporting research throughout the ACC. 78 ACC members have used the Core in the reporting period of 10/01/13-09/31/14, and ACC member usage constitutes 100% of the total Core usage. CCSG support represents 21% of the proposed Core budget, with the remainder coming from other research grants and Institutional funds.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA016520-42S1
Application #
9618176
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Marino, Michael A
Project Start
Project End
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
42
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Nicastri, Michael C; Rebecca, Vito W; Amaravadi, Ravi K et al. (2018) Dimeric quinacrines as chemical tools to identify PPT1, a new regulator of autophagy in cancer cells. Mol Cell Oncol 5:e1395504
Micallef, Ivana N; Stiff, Patrick J; Nademanee, Auayporn P et al. (2018) Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report. Biol Blood Marrow Transplant 24:1187-1195
Medvec, Andrew R; Ecker, Christopher; Kong, Hong et al. (2018) Improved Expansion and In Vivo Function of Patient T Cells by a Serum-free Medium. Mol Ther Methods Clin Dev 8:65-74
Acosta, Jonuelle; Wang, Walter; Feldser, David M (2018) Off and back-on again: a tumor suppressor's tale. Oncogene 37:3058-3069
Crisalli, Lisa M; Hinkle, Joanne T; Walling, Christopher C et al. (2018) Higher Donor Apheresis Blood Volumes Are Associated with Reduced Relapse Risk and Improved Survival in Reduced-Intensity Allogeneic Transplantations with Unrelated Donors. Biol Blood Marrow Transplant 24:1203-1208
Mazaleuskaya, Liudmila L; Salamatipour, Ashkan; Sarantopoulou, Dimitra et al. (2018) Analysis of HETEs in human whole blood by chiral UHPLC-ECAPCI/HRMS. J Lipid Res 59:564-575
Facompre, Nicole D; Harmeyer, Kayla M; Sahu, Varun et al. (2018) Targeting JARID1B's demethylase activity blocks a subset of its functions in oral cancer. Oncotarget 9:8985-8998
Rosenfeld, Aaron M; Meng, Wenzhao; Chen, Dora Y et al. (2018) Computational Evaluation of B-Cell Clone Sizes in Bulk Populations. Front Immunol 9:1472
Shroff, Rachna T; Hendifar, Andrew; McWilliams, Robert R et al. (2018) Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation. JCO Precis Oncol 2018:
Fraietta, Joseph A; Lacey, Simon F; Orlando, Elena J et al. (2018) Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nat Med 24:563-571

Showing the most recent 10 out of 1047 publications